title: Positive surgical margins in nephron-sparing surgery: risk factors and therapeutic consequences.
abstract: The increased use of nephron-sparing surgery to treat localized renal cell carcinoma (RCC) lends weight to the question of the value of microscopically positive surgical margins (PSM) in cases with a tumor bed macroscopically free of residual tumor. The aim of this article is to highlight the data available on risk factors for PSM, their clinical relevance, and possible therapeutic consequences. For this purpose, publications on the incidence and relevance of PSM after partial nephrectomy from the last 15 years were examined and evaluated. We summarize that PSM are generally rare, regardless of the surgical procedure, and are seen more often in connection with an imperative indication for nephron-sparing surgery as well as a central tumor location. Most studies describe that PSM lead to a moderate increase in the rate of local relapses, but no study has thus far been able to demonstrate an association with shorter tumor-specific overall survival. Intraoperative frozen section analysis had no positive influence on the risk of definite PSM in most trials. Therefore, we conclude that PSM should definitely be avoided. However, in cases with a macroscopically tumor-free intraoperative resection bed, they should lead to close surveillance of the affected kidney and not to immediate (re)intervention.
authors.affiliation: Department of Urology, Münster University Medical Center, Albert-Schweitzer-Campus 1, Building A1, 48149 Münster, Germany. Julie@steinestel.com.
authors.forename: Julie
authors.initials: J
authors.lastname: Steinestel
authors.forename: Sandra
authors.initials: S
authors.lastname: Steffens
authors.forename: Konrad
authors.initials: K
authors.lastname: Steinestel
authors.forename: Andres Jan
authors.initials: AJ
authors.lastname: Schrader
mesh_terms: D006801:Humans; D007680:Kidney Neoplasms / Q000150:complications* / Q000473:pathology / Q000601:surgery; D018365:Neoplasm, Residual / Q000209:etiology / Q000473:pathology*; D009392:Nephrectomy / Q000009:adverse effects*; D009399:Nephrons; D059351:Organ Sparing Treatments; D011183:Postoperative Complications / Q000209:etiology / Q000473:pathology*; D011379:Prognosis; D012307:Risk Factors
references.citation: J Urol. 2006 Dec;176(6 Pt 1):2401-4
references.pmid: 17085113
references.citation: Eur Urol. 2010 Sep;58(3):398-406
references.pmid: 20633979
references.citation: Urology. 2006 May;67(5):923-6
references.pmid: 16635521
references.citation: Urology. 2010 Jun;75(6):1328-34
references.pmid: 20080290
references.citation: J Urol. 2009 Jan;181(1):55-61; discussion 61-2
references.pmid: 19012918
references.citation: BJU Int. 2003 Oct;92(6):567-71
references.pmid: 14511035
references.citation: Eur Urol. 2006 Dec;50(6):1263-8; discussion 1269-71
references.pmid: 16787695
references.citation: Eur Urol. 2009 Jun;55(6):1410-8
references.pmid: 18692300
references.citation: J Urol. 2009 Feb;181(2):500-5
references.pmid: 19084870
references.citation: World J Surg Oncol. 2011 Oct 12;9:126
references.pmid: 21992771
references.citation: Urology. 2010 Feb;75(2):277-80
references.pmid: 19896179
references.citation: Eur Urol. 2011 Jun;59(6):931-7
references.pmid: 21371812
references.citation: Eur Urol. 2011 Apr;59(4):543-52
references.pmid: 21186077
references.citation: Int Urol Nephrol. 2013 Apr;45(2):381-5
references.pmid: 23386247
references.citation: Eur Urol. 2009 May;55(5):1171-8
references.pmid: 19232819
references.citation: Urology. 2002 Dec;60(6):993-7
references.pmid: 12475656
references.citation: Eur J Cancer. 2014 Mar;50(4):739-45
references.pmid: 24321262
references.citation: Eur Urol. 2010 Aug;58(2):293-8
references.pmid: 20546991
references.citation: J Urol. 2003 Jul;170(1):64-8
references.pmid: 12796646
references.citation: Ann Surg Oncol. 2011 Apr;18(4):1151-7
references.pmid: 21136181
references.citation: J Urol. 2009 Jan;181(1):35-41
references.pmid: 19012929
references.citation: Ann Surg Oncol. 2010 Feb;17(2):544-51
references.pmid: 19953334
references.citation: J Endourol. 2008 May;22(5):953-7
references.pmid: 18363510
references.citation: Eur Urol. 2012 Apr;61(4):757-63
references.pmid: 22136987
references.citation: Eur Urol. 2014 Feb;65(2):372-7
references.pmid: 23850254
references.citation: Eur Urol. 2010 Jun;57(6):1080-6
references.pmid: 20188458
references.citation: J Urol. 2007 Jul;178(1):41-6
references.pmid: 17574056
references.citation: BJU Int. 2011 Jul;108(2):268-73
references.pmid: 21044241
references.citation: BJU Int. 2004 Dec;94(9):1323-8
references.pmid: 15610114
references.citation: Eur Urol. 2011 Mar;59(3):333-9
references.pmid: 21109345
references.citation: BJU Int. 2006 Jun;97(6):1211-5
references.pmid: 16686713
references.citation: J Urol. 2005 Apr;173(4):1098-101
references.pmid: 15758709
references.citation: J Urol. 2009 Oct;182(4):1271-9
references.pmid: 19683266
references.citation: J Urol. 2013 Nov;190(5):1674-9
references.pmid: 23764077
references.citation: Urology. 2010 Feb;75(2):282-7
references.pmid: 19962732
references.citation: Ann Surg Oncol. 2012 Feb;19(2):694-700
references.pmid: 21861225
references.citation: J Urol. 2002 Jan;167(1):61-4
references.pmid: 11743276
references.citation: Urology. 2006 Jun;67(6):1169-74; discussion 1174
references.pmid: 16765174
references.citation: Urology. 2012 Aug;80(2):347-53
references.pmid: 22698478
references.citation: Eur Urol. 2010 May;57(5):815-20
references.pmid: 20116163
references.citation: J Urol. 2008 Feb;179(2):468-71; discussion 472-3
references.pmid: 18076931
references.citation: Clin Genitourin Cancer. 2013 Dec;11(4):527-36
references.pmid: 23871293
references.citation: Urology. 2011 Jun;77(6):1400-3
references.pmid: 21411126
references.citation: J Urol. 2005 May;173(5):1690-4
references.pmid: 15821559
references.citation: J Endourol. 2013 Mar;27(3):324-7
references.pmid: 22963602
references.citation: Eur Urol. 2007 Jun;51(6):1606-15
references.pmid: 17140723
references.citation: Clin Genitourin Cancer. 2013 Mar;11(1):5-9
references.pmid: 23083800
references.citation: Lancet Oncol. 2006 Sep;7(9):735-40
references.pmid: 16945768
references.citation: BJU Int. 2007 Feb;99(2):286-9
references.pmid: 17155985
references.citation: Urology. 2006 Nov;68(5):960-3
references.pmid: 17113887
references.citation: J Urol. 2006 Mar;175(3 Pt 1):849-52
references.pmid: 16469563
references.citation: J Urol. 2005 Feb;173(2):385-7
references.pmid: 15643176
references.citation: Aktuelle Urol. 2014 Jan;45(1):21-32
references.pmid: 24500957
references.citation: BJU Int. 2011 May;107(9):1394-9
references.pmid: 21166766
references.citation: Mayo Clin Proc. 2000 Dec;75(12):1236-42
references.pmid: 11126830
references.citation: World J Urol. 2011 Jun;29(3):343-8
references.pmid: 20623290
references.citation: Eur J Surg Oncol. 2013 Jul;39(7):799-803
references.pmid: 23566551
references.citation: BJU Int. 2013 Jun;111(8):E300-5
references.pmid: 23305148
references.citation: Can J Urol. 2013 Jun;20(3):6778-84
references.pmid: 23783047
references.citation: J Urol. 2007 Jul;178(1):47-50; discussion 50
references.pmid: 17574057
references.citation: Urology. 2013 Nov;82(5):1071-5
references.pmid: 24044918
references.citation: J Urol. 2008 Jun;179(6):2158-63
references.pmid: 18423758
references.citation: J Urol. 2009 Sep;182(3):866-72
references.pmid: 19616229
references.citation: Eur Urol. 2012 May;61(5):972-93
references.pmid: 22405593
references.citation: BJU Int. 2011 Jun;107(12):1886-92
references.pmid: 21070570
references.citation: Eur Urol. 2007 Jul;52(1):148-54
references.pmid: 17240036
references.citation: J Urol. 2002 Dec;168(6):2395-400
references.pmid: 12441925
references.citation: J Urol. 2011 May;185(5):1604-10
references.pmid: 21419454
references.citation: Eur Urol. 2010 Mar;57(3):466-71
references.pmid: 19359089